A Review of the Source Document Verification Process in Clinical Trials
被引:0
作者:
Malcolm L. Schuyl
论文数: 0引用数: 0
h-index: 0
机构:Clinical Compliance,
Malcolm L. Schuyl
Thim Engel
论文数: 0引用数: 0
h-index: 0
机构:Clinical Compliance,
Thim Engel
机构:
[1] Clinical Compliance,
[2] Asia Pacific and Japan Regions,undefined
[3] Glaxo Wellcome plc,undefined
[4] Glaxo Wellcome plc,undefined
来源:
Drug information journal : DIJ / Drug Information Association
|
1999年
/
33卷
/
3期
关键词:
Good clinical practice;
Clinical trials;
Source data;
Study monitor;
Access;
Document verification;
D O I:
暂无
中图分类号:
学科分类号:
摘要:
Confirming that accurate and reliable information has been reported by the investigator to the sponsor during clinical trials is a fundamental requirement of good clinical practice (GCP), and there can be significant implications if this is not undertaken appropriately. Yet, there is still much uncertainty surrounding this process, generally referred to as source document verification (SDV). This paper attempts to identify and discuss the main considerations to enable an effective and appropriate SDV system to be implemented.